This is a news story, published by ABC News, that relates primarily to Steven Rosenberg news.
For more Steven Rosenberg news, you can click here:
more Steven Rosenberg newsFor more biology news, you can click here:
more biology newsFor more news from ABC News, you can click here:
more news from ABC NewsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
Key cancer trial. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest immunotherapy researcher news, promising trial news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
cancer trialABC News
•Science
Science
79% Informative
Key cancer trial resumes after 'roller coaster' funding cuts threatened to derail it.
NIH director lifts hiring freeze, easing purchasing restrictions allowing scientists to recruit scientists.
Lead researcher Dr. Steven Rosenberg : "That was a roller coaster for several weeks , but it's now being corrected" "I am very grateful because that means patients won't have to wait," Melinda Bachini says.
VR Score
85
Informative language
89
Neutral language
20
Article tone
informal
Language
English
Language complexity
54
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links
Small business owner?